 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
FDA Official Discusses Issues with Regulating NGS Dx Tests
June 20, 2012
FDA Official Discusses Issues with Regulating NGS Dx Tests
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- At AGBT, FDA Official Says Agency Will Regulate NGS-based Tests, Stressing 'Nothing is Finalized'
February 27, 2013 / Clinical Sequencing News - Outbreak Tracking and Monitoring Emerges as Key Application for NGS in 2012
December 19, 2012 / Clinical Sequencing News - Incidental Findings from Sequencing Studies Should be Returned, Say Genetics Specialists
March 21, 2012 / Clinical Sequencing News - Q&A: Matt Posard on Illumina's Clinically Focused Business Unit
March 14, 2012 / Clinical Sequencing News - BGI to Demo RNA-seq's Ability to Predict Patient Outcomes as Part of FDA-Led SEQC Project
November 9, 2011 / Clinical Sequencing News